Showcasing Model Selection Case Studies to Highlight Strategic Preclinical Decision-Making

  • Presenting humanized and knock-in preclinical models to solve distinct research challenges and achieve relevant pharmacodynamic and efficacy insights
  • Discussing model selection rationale and how to tailor the model to the underlying biology
  • Sharing lessons learned to inform broader preclinical strategies and guide model selection across diverse therapeutic programs